Medicine and Dentistry
Hydrazide
100%
4 Hydroxybenzoic Acid
100%
Gastric Inhibitory Polypeptide
100%
Glucagon
100%
Insulin Release
33%
Receptor
25%
In Vitro
16%
Blood Glucose
16%
Maturity Onset Diabetes of the Young
8%
Adipocyte
8%
Glucagon Like Peptide 1
8%
Hyperglucagonemia
8%
Lipid Storage
8%
Blood Plasma
8%
Insulin Resistance
8%
Gastric Inhibitory Polypeptide Analogues
8%
Oral Drug Administration
8%
Diabetic Obesity
8%
Receptor Antagonist
8%
Pharmacology, Toxicology and Pharmaceutical Science
Gastric Inhibitory Polypeptide
100%
Glucagon
100%
4 Hydroxybenzoic Acid
100%
Hydrazide
100%
Gastric Inhibitory Polypeptide Receptor
33%
Glucagon-Like Peptide-1
8%
Receptor Antagonist
8%
Diabetic Obesity
8%
Insulin Resistance
8%
Hyperglucagonemia
8%
Non Insulin Dependent Diabetes Mellitus
8%
Biochemistry, Genetics and Molecular Biology
Gastric Inhibitory Polypeptide
100%
Molecular Weight
100%
Glucagon
100%
Insulin Release
33%
Gastric Inhibitory Polypeptide Receptor
33%
Cyclic Adenosine Monophosphate
25%
Glucose Blood Level
16%
Insulin Blood Level
16%
Receptor Antagonist
8%
Glucagon-Like Peptide-1
8%
Lipid Storage
8%
Adipocyte
8%
Insulin Resistance
8%
Agricultural and Biological Sciences
4-Hydroxybenzoic Acid
100%
Gastric Inhibitory Polypeptide
100%
Glucagon
100%
Insulin Secretion
33%
Gastric Inhibitory Polypeptide Receptor
33%
Blood Glucose
16%
Insulin Resistance
8%
Mouse
8%
Adipocyte
8%
Blood Plasma
8%
Glucagon-Like Peptide-1
8%